Real-life Study of the Efficacy of Management of Migraine Patients After Failure of 2 Prophylactic Treatments

CompletedOBSERVATIONAL
Enrollment

127

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

March 1, 2024

Conditions
Migraine
Interventions
BEHAVIORAL

Patient health care observational follow up after 2 prophylactic tratments

Real-life, observational, single-center cohort study to describe the efficacy of prophylactic treatment in patients after failure of at least 2 prophylactic treatments. Patients included in the study will be followed up in consultations or day hospitals according to their usual care, and will be asked to complete the MIDAS, HIT-6, PGIC, HAD and WPAI questionnaires at each visit. Data describing their care will be extracted from computerized patient records.

Trial Locations (1)

57085

CHR Metz-Thionville/Hopital de Mercy, Metz

All Listed Sponsors
lead

Centre Hospitalier Régional Metz-Thionville

OTHER

NCT05947123 - Real-life Study of the Efficacy of Management of Migraine Patients After Failure of 2 Prophylactic Treatments | Biotech Hunter | Biotech Hunter